Skip to Content

Newsletter No. 87 -- May 2006

Newsletter No. 87 -- May 2006

NIH - New Funding Initiatives

1. Novel Technologies For In Vivo Imaging (R21/R33) (NCI) (PA-06-398) AND (R33)(PA-06-399)
Application Receipt/Submission Date(s): Multiple dates, see announcement
The NCI is soliciting Phased Innovation (R21/R33) and Phase II, Development (R33) grant applications that propose the development and delivery of novel image acquisition or enhancement technologies and methods for biomedical imaging and image-guided interventions and therapy, and which may incorporate limited pilot or clinical feasibility evaluations using either pre-clinical models or clinical studies. This FOA is primarily intended to facilitate the proof-of-feasibility, development, and delivery of novel imaging technologies for early detection, screening, diagnosis, image-guided interventions, and treatment of various diseases, and, secondarily, to facilitate limited evaluation studies to show proof-of-concept and functionality.
R231/R33 URL: http://grants.nih.gov/grants/guide/pa-files/PA-06-398.html
R33 URL: http://grants.nih.gov/grants/guide/pa-files/PA-06-399.html

2. IN VIVO CELLULAR AND MOLECULAR IMAGING CENTERS (ICMICS)[P50] (NCI) (PAR-06-406) Application Receipt/Submission Date(s): August 16, 2006; August 16, 2007
The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the progress in molecular imaging as the basis for the extraordinary, non-invasive and quantitative analytical tools useful in the diagnosis and treatment of cancer as well as in the laboratory environment to interrogate biological pathways relevant to cancer. The Cancer Imaging Program of the NCI solicits new or competing applications for P50 Research Center Grants for In Vivo Cellular and Molecular Imaging Centers (ICMICs). The program will fund the 5-year P50 ICMIC grants to support interdisciplinary scientific teams conducting cutting-edge cancer molecular imaging research with clinical relevance. ICMIC funding is designed to: (1) support unique core facilities; (2) enable the awardees to initiate pilot research in new promising directions; and (3) provide interdisciplinary career development opportunities for investigators new to the field of molecular cancer imaging.
URL: http://grants.nih.gov/grants/guide/pa-files/PAR-06-406.html

3. IN VIVO CANCER IMAGING EXPLORATORY/DEVELOPMENTAL GRANTS (R21) (NCI) (PA-06-371)
Application Receipt Date(s): Multiple dates, see announcement
The Cancer Imaging Program (CIP) of the Division of Cancer Treatment and Diagnosis (DCTD) solicits exploratory/developmental (R21) applications that articulate high risk and/or high impact research focused on in vivo cancer imaging for detection, diagnosis, and monitoring of response to therapy. Topics considered responsive to this Funding Opportunity Announcement (FOA) will cover the entire spectrum of in vivo cancer imaging research, from basic discovery of new cancer imaging agents and technologies, through pre-clinical testing and validation, to the early feasibility testing of those novel agents and technologies in small clinical trials.
URL: http://grants.nih.gov/grants/guide/pa-files/PA-06-371.html

4. NEW TECHNOLOGIES FOR LIVER DISEASE STTR (R41/R42) (PA-06-396) AND (R43/R44)(PA-06-397)
Application Receipt/Submission Date(s): Multiple dates, see announcement
Several NIH institutes are solicit applications to develop resources, research tools, instrumentations, biomarkers, devices, drugs or new and innovative approaches to diagnosis, monitoring, management, treatment and prevention of liver diseases. Areas of interest include development of reliable and practical means of diagnosis of liver diseases; biomarkers for disease activity and stage; noninvasive tests for inflammation, fibrosis and fat in the liver; and drugs, complementary and alternative modalities, biologics or molecular reagents for the therapy or prevention of liver diseases. The goal of this announcement is to enlist members of the small business research community in advancing means of diagnosis, treatment and prevention of liver disease and facilitate the goals outlined in the trans-NIH "Action Plan for Liver Disease Research."
STTR URL: http://grants.nih.gov/grants/guide/pa-files/PA-06-396.html
SBIR URL: http://grants.nih.gov/grants/guide/pa-files/PA-06-397.html

5. INNOVATIONS IN BIOMEDICAL COMPUTATIONAL SCIENCE AND TECHNOLOGY (R01) (PAR-06-410)
Application Receipt Date(s): June 24, 2006; September 24, 2006; January 24, 2007; May 24, 2007; September 24, 2007; January 24, 2008; May 24, 2008; September 24, 2008, January 24, 2009
The NIH is interested in promoting research and developments in computational science and technology that will support rapid progress in areas of scientific opportunity in biomedical research. As defined here, biomedical computing or biomedical information science and technology includes database design, graphical interfaces, querying approaches, data retrieval, data visualization and manipulation, data integration through the development of integrated analytical tools, and tools for electronic collaboration, as well as computational and mathematical research including the development of structural, functional, integrative, and analytical models and simulations.
URL: http://grants.nih.gov/grants/guide/pa-files/PAR-06-410.html

6. EXPLORATORY INNOVATIONS IN BIOMEDICAL COMPUTATIONAL SCIENCE AND TECHNOLOGY (R21) (PAR-06-411)
Application Receipt Date(s): June 24, 2006; September 24, 2006; January 24, 2007; May 24, 2007; September 24, 2007; January 24, 2008; May 24, 2008; September 24, 2008, January 24, 2009
This particular FOA is intended to support exploratory biomedical informatics and computational biology research-applications should be innovative, with high risk/high impact in new areas that are lacking preliminary data or development. Applications for R21 awards should describe projects distinct from those supported through the traditional R01 mechanism. Areas of biomedical research likely to be critically dependent on biocomputing advances include but are not limited to: behavioral science, biological rhythms, biomedical imaging, cell biology, etc.
URL: http://grants.nih.gov/grants/guide/pa-files/PAR-06-411.html

7. SELECTION OF APPROPRIATE FUNDING OPPORTUNITY ANNOUNCEMENTS (FOAS) FOR THE INNOVATIVE TECHNOLOGIES FOR MOLECULAR ANALYSIS OF CANCER (IMAT) PROGRAM (NCI) (NOT-CA-06-025)
The NCI-sponsored Innovative Technologies for Molecular Analysis of Cancer (IMAT) Program, which is aimed at the development and integration of novel and emerging technologies in the support of cancer research, diagnosis, and treatment, now encompasses an array of 14 closely-related Funding Opportunity Announcements (FOAs). Researchers who emphasize the assessment of in vivo imaging technologies as the primary focus of their grant applications should contact the Cancer Imaging Program for information on appropriate funding opportunities.
URL: http://grants.nih.gov/grants/guide/notice-files/NOT-CA-06-025.html

8. RUTH L. KIRSCHSTEIN NATIONAL RESEARCH SERVICE AWARDS (NRSA) FOR INDIVIDUAL POSTDOCTORAL FELLOWS (F32) (PA-06-373)
The objective of the National Research Service Award (NRSA) F32 program is to provide support to promising postdoctoral applicants who have the potential to become productive and successful independent research investigators in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers (ICs).
URL: http://grants.nih.gov/grants/guide/pa-files/PA-06-373.html

Announcements

Reminder: All R03, R21, R21/R33, R33 and R34 Grant Applications Must Use SF424 (R&R) and Grants.gov for the June 1, 2006, Submission Date and Beyond (NOT-OD-06-068)
URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-06-068.html

MULTIPLE PI IMPLEMENTATION UPDATE (NOT-OD-06-069)
URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-06-069.html

JOB ANNOUNCEMENT:

SCIENTIFIC CURATOR - NIH IMAGING AGENT DATABASE
Computercraft seeks an experienced imaging scientist to provide curatorial responsibilities for implementing and maintaining the NIH imaging agent database. The individual will work with NIH staff scientists and extramural advisors onsite at the NIH campus. Join our team of highly skilled and dedicated professionals as we participate in the development of a new centralized database of in vivo imaging agents. This innovative database will include agents developed for position-emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), ultrasound and optical imaging. The database will be located within the National Center for Biotechnology Information (NCBI) at the National Institutes of Health (NIH). This diversified and challenging position requires a Ph.D. (strongly preferred) or M.S. degree in imaging sciences or highly related field. The successful candidate will have a demonstrable knowledge of the chemistry and developmental process of in vivo imaging agents, experience with current analytical tools in both chemistry and biology, and a working knowledge of the issues associated with the information technology and cheminformatics required to successfully implement this database. The ability to extract and summarize scientific information in a textual format is essential. Contact Computercraft for details.
Email: hr@computercraft-usa.com
Fax: (301) 493-1288
Mail: Computercraft, Attn: HR, 6701 Democracy Blvd.,Suite 401, Bethesda, MD 20817

Interagency Council on Biomedical Imaging in Oncology Meeting
The next ICBIO meeting is Tuesday, October 17, 2006, from 8:30 AM in EPN, at 6130 Executive Boulevard, Rockville, MD. The deadline for submission is August 31, 2006. See http://imaging.cancer.gov/programsandresources/specializedinitiatives/ICBIO for details.

CIP DCIDE PROGRAM
The Cancer Imaging Program of the NCI requests submissions for its Development of Clinical Imaging Drugs and Enhancers (DCIDE) initiative. The goal is the rapid movement of promising, novel cancer imaging enhancers or molecular probes from the laboratory to proof of principle clinical trials. See the web site for details.
URL: http://imaging.cancer.gov/programsandresources/specializedinitiatives/dcide

NIH COMMONS
The NIH Commons web site allows all NIH grantee organizations to interact with grants data, to check the status of grant applications, including viewing scores and summary statements when they are ready, and to submit progress reports on line, among a number of functions. Applicants and grants administrators should become familiar with the Commons. URL: https://commons.era.nih.gov/commons/index.jsp

Meetings

SOCIETY OF NUCLEAR MEDICINE 53RD ANNUAL MEETING
San Diego, California, June 3-7, 2006. Look for CIP in booth 107.
URL: http://www.snm.org

WORLD CONFERENCE ON INTERVENTIONAL ONCOLOGY
June 12-16, 2006, Cernobbio, Italy
URL: http://www.wcio2006.com/committees-chairs.htm

CARS 2006 COMPUTER ASSISTED RADIOLOGY AND SURGERY - 20TH INTERNATIONAL CONGRESS AND EXHIBITION
June 28 - July 1, 2006, Osaka Japan
URL: http://www.cars-int.org/

SOCIETY OF MOLECULAR IMAGING
Hilton Waikoloa Village, Hawaii, Hawaii, August 30-September 2, 2006
URL: http://www.molecularimaging.org/2006meeting/home06.php

IMAGING AS A BIOMARKER: STANDARDS FOR CHANGE MEASUREMENTS IN THERAPY
September 14 - 15, 2006, Gaithersburg, Maryland
URL: http://usms.nist.gov/workshops/bioimaging.htm

INTERNATIONAL CONFERENCE ON QUALITY ASSURANCE AND NEW TECHNIQUES IN RADIATION MEDICINE (QANTRM)
November 13-15, 2006, Vienna, Austria. Organized by the International Atomic Energy Agency
URL: http://www-pub.iaea.org/MTCD/Meetings/Announcements.asp?ConfID=146

RSNA 2006
November 26 - December 1, 2006, McCormick Place, Chicago, IL
URL: http://rsna2006.rsna.org/rsna2006/V2006/index.cvn

17TH INTERNATIONAL SYMPOSIUM ON RADIOPHARMACEUTICAL SCIENCES
April 30 - May 4, 2007, Aachen, Germany
URL: http://srs.snm.org/docs/AD-ISRS-Final.pdf

The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.

If you wish to remain on the list, no action is necessary. If you wish to be added to the list, please contact Dr Barbara Croft by return e-mail (bc129b@nih.gov). Please include your complete mailing address, title, phone and fax numbers.

Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
6130 Executive Boulevard - MSC-7412
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507